Tumor Cell Distinguishable Nanomedicine Integrating Chemotherapeutic Sensitization and Protection
Theoretically, with a high enough drug dosage, cancer cells could be eliminated. However, the dosages that can be administered are limited by the therapeutic efficacy and side effects of the given drug. Herein, a nanomedicine integrating chemotherapeutic sensitization and protection was developed to...
Guardado en:
Autores principales: | Sen Liu, Can Shen, Cheng Qian, Jianquan Wang, Zhongmei Yang, Yanchun Wei, Li Quan, Changjiang Pan, Yong Hu, Wei Ye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06b282931d6c4365bbccc1bf38c17398 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening
por: Yordan Sbirkov, et al.
Publicado: (2021) -
A Rapid Dual-Responsive Releasing Nano-Carrier by Decomposing the Copolymer and Reversing the Core Dissolution
por: Sen Liu, et al.
Publicado: (2021) -
Silver Nanotriangles and Chemotherapeutics Synergistically Induce Apoptosis in Glioma Cells via a ROS-Dependent Mitochondrial Pathway
por: Yang H, et al.
Publicado: (2020) -
A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
por: Maolin Wang, et al.
Publicado: (2021) -
DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
por: van Valenberg FJP, et al.
Publicado: (2021)